These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2240084)

  • 1. Prevalence and determinants of estrogen replacement therapy in elderly women.
    Cauley JA; Cummings SR; Black DM; Mascioli SR; Seeley DG
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1438-44. PubMed ID: 2240084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.
    Cauley JA; Seeley DG; Ensrud K; Ettinger B; Black D; Cummings SR
    Ann Intern Med; 1995 Jan; 122(1):9-16. PubMed ID: 7985914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis and fractures in postmenopausal women using estrogen.
    Nelson HD; Rizzo J; Harris E; Cauley J; Ensrud K; Bauer DC; Orwoll E;
    Arch Intern Med; 2002 Nov; 162(20):2278-84. PubMed ID: 12418942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen replacement therapy. A survey of older women's attitudes.
    Salamone LM; Pressman AR; Seeley DG; Cauley JA
    Arch Intern Med; 1996 Jun; 156(12):1293-7. PubMed ID: 8651837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE).
    Handa VL; Landerman R; Hanlon JT; Harris T; Cohen HJ
    J Am Geriatr Soc; 1996 Jan; 44(1):1-6. PubMed ID: 8537578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study.
    Jonas HA; Kronmal RA; Psaty BM; Manolio TA; Meilahn EN; Tell GS; Tracy RP; Robbins JA; Anton-Culver H
    Ann Epidemiol; 1996 Jul; 6(4):314-23. PubMed ID: 8876842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures.
    Nguyen TV; Jones G; Sambrook PN; White CP; Kelly PJ; Eisman JA
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2709-14. PubMed ID: 7673413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
    Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
    N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group.
    Nevitt MC; Cummings SR; Lane NE; Hochberg MC; Scott JC; Pressman AR; Genant HK; Cauley JA
    Arch Intern Med; 1996 Oct; 156(18):2073-80. PubMed ID: 8862099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing profiles of postmenopausal women being prescribed estrogen therapy to prevent osteoporosis.
    Amonkar MM; Mody R
    J Community Health; 2002 Oct; 27(5):335-50. PubMed ID: 12238732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premenopausal determinants of menopausal estrogen use.
    Egeland GM; Kuller LH; Matthews KA; Kelsey SF; Cauley J; Guzick D
    Prev Med; 1991 May; 20(3):343-9. PubMed ID: 1862056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
    Matthews KA; Kuller LH; Wing RR; Meilahn EN; Plantinga P
    Am J Epidemiol; 1996 May; 143(10):971-8. PubMed ID: 8629615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are women using postmenopausal estrogens? A community survey.
    Harris RB; Laws A; Reddy VM; King A; Haskell WL
    Am J Public Health; 1990 Oct; 80(10):1266-8. PubMed ID: 2400044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.